Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup

Topics in Magnetic Resonance Imaging

Volumn 16, Issue 6, 2005, Pages 427-437

  Wahlund, Lars Olof ^a,g   Almkvist, Ove ^a   Blennow, Kaj ^b   Engedahl, Knut ^d   Johansson, Aki ^e   Waldemar, Gunhild ^c   Wolf, Henrike ^f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Rigshospitalet   (Denmark)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e LUND UNIVERSITY   (Sweden)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer disease; Dementia workup; Diagnosis; Evidence based medicine; Likelihood ratios; Magnetic resonance imaging; Medial temporal lobe; Sensitivity; Specificity

Indexed keywords

BRAIN ATROPHY; BRAIN REGION; DEMENTIA; HIPPOCAMPUS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE;

EID: 33750689880     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000245463.36148.12     Document Type: Review

References (42)

1. Association AP. DSM-IV, Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994.
2. World Health Organization. ICD-10, World Health Organization Tenth Revision of the International Classification of Diseases. Geneva: WHO; 1992.
3. Waldemar G, Dubois B, Emre M, et al. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol. 2000;7(2):133-144.
4. Practice parameter for diagnosis and evaluation of dementia (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1994;44(11):2203-2206.
5. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1143-1153.
6. Qizilbash N, Schneider L, Chui H, et al. Diagnosis in Evidence-based Dementia Practice. Oxford, UK: Blackwell Publishing Co; 2002:81-85.
7. Killiany RJ, Hyman BT, Gomez-Isla T, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 2002;58(8):1188-1196.
8. de Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol. 1993;14(4):897-906.
9. Xu Y, Jack CR Jr, O'Brien PC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54(9):1760-1767.
10. Laakso M, Soininen H, Partanen K, et al. The interuncal distance in Alzheimer disease and age-associated memory impairment. AJNR Am J Neuroradiol. 1995;16(4):727-734.
11. Laakso MP, Partanen K, Lehtovirta M, et al. MRI of amygdala fails to diagnose early Alzheimer's disease. Neuroreport. 1995;6(17):2414-2418.
12. El Fakhri G, Kijewski MF, Johnson KA, et al. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Arch Neurol. 2003;60(8):1066-1072.
13. Kantarci K, Xu Y, Shiung MM, et al. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14(4):198-207.
14. Bottino CM, Castro CC, Gomes RL, et al. Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. Int Psychogeriatr. 2002;14(1):59-72.
15. Pennanen C, Kivipelto M, Tuomainen S, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004;25(3):303-310.
16. Jobst KA, Barnetson LP, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, x-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Int Psychogeriatr. 1998;10(3):271-302.
17. Rossi R, Joachim C, Smith AD, et al. The CT-based radial width of the temporal horn: pathological validation in AD without cerebrovascular disease. Int J Geriatr Psychiatry. 2004;19(6):570-574.
18. Wahlund LO, Julin P, Johansson SE, et al. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry. 2000;69(5):630-635.
19. O'Brien JT, Desmond P, Ames D, et al. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychol Med. 1997;27(6):1267-1275.
20. Lavenu I, Pasquier F, Lebert F, et al. Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1997;63(4):441-445.
21. Denihan A, Wilson G, Cunningham C, et al. CT measurement of medial temporal lobe atrophy in Alzheimer's disease, vascular dementia, depression and paraphrenia. Int J Geriatr Psychiatry. 2000;15(4):306-312.
22. Varma AR, Adams W, Lloyd JJ, et al. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand. 2002;105(4):261-269.
23. O'Brien JT, Metcalfe S, Swann A, et al. Medial temporal lobe width on CT scanning in Alzheimer's disease: comparison with vascular dementia, depression and dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2000;11(2):114-118.
24. Barber R, Gholkar A, Scheltens P, et al. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology. 1999;52(6):1153-1158.
25. Kitagaki H, Mori E, Hirono N, et al. Alteration of white matter MR signal intensity in frontotemporal dementia. AJNR Am J Neuroradiol. 1997;18(2):367-378.
26. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology. 1995;195(1):65-72.
27. Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet. 2000;355(9213):1412-1418.
28. Bigler ED, Tate DF. Brain volume, intracranial volume, and dementia. Invest Radiol. 2001;36(9):539-546.
29. Gosche KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. 2002;58(10):1476-1482.
30. O'Brien JT, Ames D, Desmond P, et al. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls. Int Psychogeriatr. 2001;13(2):149-161.
31. Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging. 1998;19(1):23-31.
32. Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol. 1993;50(3):305-310.
33. Laakso MP, Hallikainen M, Hanninen T, et al. Diagnosis of Alzheimer's disease: MRI of the hippocampus vs delayed recall. Neuropsychologia. 2000;38(5):579-584.
34. O'Brien JT, Desmond P, Ames D, et al. The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol Med. 1994;24(3):633-640.
35. Juottonen K, Laakso MP, Insausti R, et al. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol Aging. 1998;19(1):15-22.
36. Frisoni GB, Beltramello A, Geroldi C, et al. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1996;61(2):157-165.
37. Golebiowski M, Barcikowska M, Pfeffer A. Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type. Dement Geriatr Cogn Disord. 1999;10(4):284-288.
38. DeCarli C, Murphy DG, McIntosh AR, et al. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res. 1995;57(2):119-130.
39. Frisoni GB, Geroldi C, Beltramello A, et al. Radial width of the temporal horn: a sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol. 2002;23(1):35-47.
40. Koslow SA, Swihart AA, Latchaw RE, et al. Quantitative computer tomography in Alzheimer's disease: a re-evaluation. Gerontology. 1992;38(3):174-184.
41. Du AT, Schuff N, Zhu XP, et al. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology. 2003;60(3):481-486.
42. Gao FQ, Black SE, Leibovitch FS, et al. Linear width of the medial temporal lobe can discriminate Alzheimer's disease from normal aging: the Sunnybrook Dementia Study. Neurobiol Aging. 2004;25(4):441-448.